REMAP-CAP : oseltamivir25 Apr 2020 12:41
Comination Therapy now working.
In an editorial that accompanies the study, a trio of experts from the University of Washington, University of Iowa, and the Minneapolis Heart Institute say that, because of the noted limitations, the only conclusion that can be made is that high doses of chloroquine, in combination with azithromycin and potentially oseltamivir, are potentially associated with increased mortality in patients with severe COVID-19.
https://www.cidrap.umn.edu/news-perspective/2020/04/fda-warns-about-hydroxychloroquine-chloroquine-covid-19